Key result
Combined FDG-PET and rest MPI detects non-granulomatous myocarditis with ~82% sensitivity.
Why the study?
Data on FDG-PET/CT in non-granulomatous myocarditis are limited, and no study had evaluated the diagnostic performance of combined FDG-PET and rest myocardial perfusion imaging (rMPI).
Does combined FDG-PET/CT with rest myocardial perfusion imaging accurately diagnose non-granulomatous myocarditis in patients with suspected disease?
Observational (n=25)
Yes
Does combined FDG-PET/CT with rest myocardial perfusion imaging accurately diagnose non-granulomatous myocarditis in patients with suspected disease?
Combining FDG-PET with rMPI is a feasible imaging modality for detecting non-granulomatous myocarditis, offering good sensitivity and specificity.
Answers are grounded in this paper and cite their sources.
May support combined FDG-PET/rMPI for suspected myocarditis; leaves open validation in larger prospective studies.
Purpose Data on the use of fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) in non-granulomatous myocarditis are limited, and no study has evaluated the diagnostic performance of combined FDG-PET and rest myocardial perfusion imaging (rMPI). Methods We conducted a multicenter prospective observational feasibility study of patients who underwent combined FDG-PET/CT with rMPI as well as cardiac magnetic resonance (CMR) for suspected myocarditis. When available, endomyocardial biopsy (EMB) established the diagnosis according to consensus criteria. Otherwise, the final adjudicated clinical diagnosis served as the reference standard. All patients had a minimum follow-up of 12 months following PET imaging. Results Twenty-five patients were included, of whom 18 (72%) were diagnosed with myocarditis. FDG-PET and rMPI demonstrated a sensitivity/specificity of 61%/100%, and 59%/71%, respectively. Inter-reader agreement for FDG-PET was excellent (κ = 0.84, 95% CI 0.62–1.00). The combination of FDG-PET and rMPI yielded a sensitivity of 82% (95% CI: 50–93%) and a specificity of 71% (95% CI: 29–96%). Late gadolinium enhancement (LGE), excluding isolated subendocardial patterns, showed a sensitivity/specificity of 72%/57%. Spatial agreement between rMPI perfusion defects and LGE on CMR was modest (κ = 0.35, 95%CI: 0.23–0.47). Conclusion Combining FDG-PET with rMPI may be a feasible imaging modality for detecting non-granulomatous myocarditis by capturing both inflammatory and fibrotic components across different disease stages.
No takes yet. Share an insight, caveat, or question.
Lucinian et al. (2026) conducted an observational in Non-granulomatous myocarditis (n=25). Combined FDG-PET and rest myocardial perfusion imaging (rMPI) vs. Cardiac magnetic resonance (CMR) and endomyocardial biopsy or clinical diagnosis was evaluated on Diagnostic sensitivity and specificity for myocarditis (Sensitivity 82%, Specificity 71%, 95% CI Sensitivity 50-93, Specificity 29-96). Combined FDG-PET and rest myocardial perfusion imaging yielded a sensitivity of 82% and specificity of 71% for detecting non-granulomatous myocarditis.
Synapse has enriched 10 related papers. Consider them for comparative context: